MedTrace Logo

Assessment of Bone Micro-Architecture Using HR-pQCT

NCT01367730 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2014-12-02

No results posted yet for this study

Summary

In the context of male osteoporosis, we hypothesize that regional changes in trabecular bone, as well as changes in cortical porosity will play a major role, and thus also affect bone strength. In developing therapeutics the response of individual compartments, regional variations post-therapy will have considerable impact on selecting the therapies as well as monitoring response to therapy. This study, a precursor to other therapeutic trials, will lay the ground-work for the future.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Sharmila Majumdar, PhD · University of California, San Francisco

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01367730 on ClinicalTrials.gov